United Kingdom
- Select a country/city
- Alliance Programme EMEA
- All Other Territories
- Austria
- Belarus
- Belgium
- Bulgaria
- Channel Islands
- Croatia
- Czech Republic - CS
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- France - FR
- Germany - DE
- Germany
- Greece
- Hungary
- Ireland
- Italy
- Italy - IT
- Kazakhstan
- Latvia
- Lithuania
- Luxembourg
- Macedonia
- Netherlands
- Netherlands - NL
- Norway
- Poland
- Portugal
- Portugal - PT
- Romania
- Russia
- Russia - RU
- Scotland
- Serbia
- Slovakia
- Slovenia
- Spain
- Spain - ES
- Sweden
- Switzerland
- Turkey
- Ukraine
- Ukraine - UA
- United Kingdom
Cushman & Wakefield »
Knowledge Center »
Business Briefings »
Business Briefing: Global Pharmaceutical Real Estate
Business Briefing: Global Pharmaceutical Real Estate
Download Report
-
It is hard to imagine a single business segment in more of a state of flux than the pharmaceutical industry, with substantial consolidation, patent expirations, technology changes and the trend toward outsourcing among challenges facing the industry. This business briefing examines current industry dynamics and how commercial real estate and facility professionals are facing these challenges.
-
You may also be interested in
